Superluminal Medicines, Inc.

Industry: Biotechnology (See others in industry)

Address:
15 Necco St. Lilly Gateway Labs, 4 Th Floor
Boston, MA, 02110
Phone: (301) 525-8752

Filings

Date Type Incremental Cash Raw Filing
2025-08-26 New Unknown SEC link
2024-09-04 New $20,041,660 SEC link
2023-08-28 New $25,679,107 SEC link

Directors and Executives (Current and Past)

Name Role
Cony D'cruz Director, Executive, Promoter
Andrew Levin Director
Dylan Morris Director
Craig Randall Executive
Catherine Riesen Executive
Diamantis Xylas Director